Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction

Cellular and Molecular Immunology

Volumn 14, Issue 5, 2017, Pages 465-475

  Yang, Yinli ^a   Han, Qiuju ^a   Hou, Zhaohua ^a   Zhang, Cai ^a   Tian, Zhigang ^b   Zhang, Jian ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

CHB; dysfunction; exosome; HBV; NK cells

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSFORMING GROWTH FACTOR BETA; VIRAL PROTEIN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHEMICAL LABELING; CHRONIC HEPATITIS B; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; EXOSOME; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEPATOMA CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER CELL; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS TRANSMISSION; CASE CONTROL STUDY; GENETICS; HEP-G2 CELL LINE; HEPATITIS B VIRUS; IMMUNOLOGY; K-562 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA, VIRAL; EXOSOMES; FEMALE; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; YOUNG ADULT;

EID: 85019143272     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2016.24     Document Type: Article

References (35)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49: S45-S55.
3. McMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am 2014; 98: 39-54.
4. Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 2007; 13: 22-38.
5. Yan H, Zhong G, Xu G, HeW, Jing Z, Gao Z et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012; 1: e00049.
6. Chahar HS, Bao X, Casola A. Exosomes and their role in the life cycle and pathogenesis of RNA viruses. Viruses 2015; 7: 3204-3225.
7. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012; 21: R125-R134.
8. Meckes Jr DG, Raab-Traub N. Microvesicles and viral infection. J Virol 2011; 85: 12844-12854.
9. Alenquer M, Amorim MJ. Exosome biogenesis, regulation, and function in viral infection. Viruses 2015; 7: 5066-5083.
10. Bukong TN, Momen-Heravi F, Kodys K, Bala S, Szabo G. Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog 2014; 10: e1004424.
11. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, Whitten-Bauer C et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012; 12: 558-570.
12. Li J, Liu K, Liu Y, Xu Y, Zhang F, Yang H et al. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat Immunol 2013; 14: 793-803.
13. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, Dunn C et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 2010; 6: e1001227.
14. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z et al. TGF-beta1 downregulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 2012; 8: e1002594.
15. Wu L, Zhang C, Zhang J. HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway. Cell Mol Immunol 2011; 8: 433-440.
16. Yang D, Zuo C, Wang X, Meng X, Xue B, Liu N et al. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc Natl Acad Sci U S A 2014; 111: E1264-E1273.
17. Untergasser A, Zedler U, Langenkamp A, Hosel M, Quasdorff M, Esser K et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006; 43: 539-547.
18. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2011; 54: 209-218.
19. Zech D, Rana S, Buchler MW, Zoller M. Tumor-exosomes and leukocyte activation: an ambivalent crosstalk. Cell Commun Signal 2012; 10: 37.
20. Tian T, Zhu YL, Hu FH, Wang YY, Huang NP, Xiao ZD. Dynamics of exosome internalization and trafficking. J Cell Physiol 2013; 228: 1487-1495.
21. Girart MV, Fuertes MB, Domaica CI, Rossi LE, Zwirner NW. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol 2007; 179: 3472-3479.
22. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-137.
23. Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I et al. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol 2010; 185: 2080-2088.
24. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science 2004; 306: 1517-1519.
25. Hosseini HM, Fooladi AA, Nourani MR, Ghanezadeh F. The role of exosomes in infectious diseases. Inflamm Allergy Drug Targets 2013; 12: 29-37.
26. Ramakrishnaiah V, Thumann C, Fofana I, Habersetzer F, Pan Q, de Ruiter PE et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci USA 2013; 110: 13109-13113.
27. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
28. Mondelli MU, Varchetta S, Oliviero B. Natural killer cells in viral hepatitis: facts and controversies. Eur J Clin Invest 2010; 40: 851-863.
29. Trippler M, Meyer zum Buschenfelde KH, Gerken G. HBV viral load within subpopulations of peripheral blood mononuclear cells in HBV infection using limiting dilution PCR. J Virol Methods 1999; 78: 129-147.
30. Lee Z, Nishikawa S, Gao S, Eksteen JB, Czub M, Gill MJ et al. Detection of hepatitis B virus (HBV) genomes and HBV drug resistant variants by deep sequencing analysis of HBV genomes in immune cell subsets of HBV mono-infected and/or human immunodeficiency virus type-1 (HIV-1) and HBV co-infected individuals. PLoS One 2015; 10: e0137568.
31. Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 2008; 180: 7249-7258.
32. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009; 137: 1151-1160 1160, e1151-1157.
33. Zou Z, Xu D, Li B, Xin S, Zhang Z, Huang L et al. Compartmentalization and its implication for peripheral immunologically-competent cells to the liver in patients with HBV-related acute-on-chronic liver failure. Hepatol Res 2009; 39: 1198-1207.
34. Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009; 49: 1132-1140.
35. Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 2010; 91: 2080-2090.